Report: Gardasil cost-effective for girls, young women

Gardasil, Merck & Co.'s human papillomavirus vaccine designed to prevent cervical cancer, is cost-effective only for preadolescent girls and women as old as 21, according to an economic analysis by Harvard University researchers. The findings support the CDC's recommendation to routinely immunize 11- and 12-year-old girls before they become sexually active.

View Full Article in:

USA Today · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Medical Director - Physician
Willamette Valley Community Health
Salem, OR